Hims & Hers Health (NYSE: HIMS)
Hims & Hers Health Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hims & Hers Health Company Info
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
News & Analysis
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Is Hims & Hers Health a Smart Buy Right Now?
Shares of Hims & Hers have crushed the market over the last year.
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space
How to Invest in iShares Russell 2000 ETF
Hims & Hers Goes on a Buying Spree
Hims & Hers is expanding into Europe in a global push the company previewed earlier this year.
3 Surprising Stocks That Have More Than Doubled in 2025
Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would have predicted.
Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock?
2 No-Brainer Growth Stocks to Buy Right Now
Valuation
Podcast Episodes
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
A New Name in Weight Loss Drugs
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.